Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX VISTA® for Masseter Muscle Prominence
NCT06137287Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Nov 2023
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in masseteric hypertrophy (MH), sponsored by AbbVie Inc.. Started Nov 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
masseteric hypertrophy (MH)
Beyond the preview
Go deeper on NCT06137287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137287.